New innovations in Vault CTMS streamlining
trial workflows and accelerating execution
across the industry
BARCELONA, Spain, May 25, 2022 /PRNewswire/ -- Veeva Systems
(NYSE: VEEV) today announced that more than 150 global enterprises
and fast-growing companies are advancing clinical trial operations
with Veeva Vault CTMS. Sponsors and contract research organizations
(CROs) are using Vault CTMS to work with over 300,000 research
sites and support more than 1 million patients across study phases.
The growth in Vault CTMS adoption is helping life sciences
companies to proactively manage trials and accelerate toward a more
connected and digital future.
Veeva continues to deliver innovations that can solve critical
trial challenges. With site monitoring, for example, customers
using Vault CTMS can save more than 465 days in generating and
filing trip reports because of automation and real-time information
sharing. In addition to the gains in productivity, using Vault CTMS
allows sponsors and CROs to improve data quality, make more
informed decisions, and keep trials on track.
With three product releases every year, Veeva is modernizing key
trial processes that can speed studies. New features for Vault CTMS
include:
- Risk-based study management for seamless clinical risk
assessment and mitigation
- Site monitoring enhancements like trip report branching and
one-click questions for faster execution
- Study oversight features that make it easier to manage
issues and protocol deviations for greater compliance
"Veeva is committed to delivering innovations that help life
sciences companies improve clinical operations so they can bring
medicines to patients faster," said Henry
Galio, vice president, Veeva Vault CTMS. "In just five years
since its launch, over 150 companies are using Veeva Vault CTMS to
significantly streamline complex trial processes like clinical risk
management and monitoring trip reports. We're proud to support the
industry and will continue to work with our customers to speed
digital trials while making them more cost-effective."
A growing number of organizations, including 10 of the top 20
pharmaceutical companies and 3 of the top 6 CROs, are using Vault
CTMS to streamline trial operations. Vault CTMS is part of the
Veeva Vault Clinical Operations Suite, enabling companies to
share information and documents across CTMS, eTMF, study start-up,
and payments for better collaboration and increased efficiency
throughout the study lifecycle.
Learn how companies are using Vault CTMS to speed processes at
Veeva R&D and Quality Summit Europe. Life sciences industry
professionals can register for the in-person event in Zurich on June
8.
Additional Information
For more on Veeva Vault CTMS,
visit: veeva.com/eu/CTMS Connect with Veeva on LinkedIn:
linkedin.com/company/veeva-systems Follow @veeva_eu on
Twitter: twitter.com/veeva_eu
About Veeva Systems
Veeva is the global leader in
cloud software for the life sciences industry. Committed to
innovation, product excellence, and customer success, Veeva serves
more than 1,000 customers, ranging from the world's largest
pharmaceutical companies to emerging biotechs. As a Public Benefit
Corporation, Veeva is committed to balancing the interests of all
stakeholders, including customers, employees, shareholders, and the
industries it serves. For more information,
visit veeva.com/eu.
Veeva Forward-looking Statements
This release contains
forward-looking statements regarding Veeva's products and services
and the expected results or benefits from use of our products and
services. These statements are based on our current expectations.
Actual results could differ materially from those provided in this
release and we have no obligation to update such statements. There
are numerous risks that have the potential to negatively impact our
results, including the risks and uncertainties disclosed in our
filing on Form 10-K for the period ended January 31, 2022, which you can
find here (a summary of risks which may impact our
business can be found on pages 13 and 14), and in our subsequent
SEC filings, which you can access at sec.gov.
Contact:
|
|
Deivis Mercado
Veeva Systems
925-226-8821
deivis.mercado@veeva.com
|
Jeremy Whittaker
Veeva Systems
+49 6950955486
jeremy.whittaker@veeva.com
|
Logo -
https://mma.prnewswire.com/media/1488285/Veeva_Systems_Logo.jpg